Worldwide Facial Injectables Industry to 2026 - Featuring Ipsen, Sanofi and Sinclair Pharma Among Others

Dublin, Sept. 27, 2021 (GLOBE NEWSWIRE) -- The "Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global facial injectables market is expected to grow at a CAGR of around 11% during 2021-2026. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.

As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth. Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals. Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.

Key Market Segmentation

The analyst provides an analysis of the key trends in each sub-segment of the global facial injectables market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on product type, application type, application and end user.

Breakup by Product Type

• Collagen

• Hyaluronic Acid (HA)

• Botulinum Toxin Type A

• Calcium Hydroxylapatite (CaHA)

• Polymethylmethacrylate Beads (PMMA Microspheres)

• Poly-L-Lactic Acid (PLLA)

• Others

Breakup by Application Type

• Aesthetics

• Therapeutics

Breakup by Application

• Facial Line Correction

• Lip Augmentation

• Face Lift

• Acne Scar Treatment

• Others

Breakup by End User

• Hospitals

• Dermatology Clinics

• Others

Breakup by Region

• North America

• United States

• Canada

• Asia-Pacific

• China

• Japan

• India

• South Korea

• Australia

• Indonesia

• Others

• Europe

• Germany

• France

• United Kingdom

• Italy

• Spain

• Russia

• Others

• Latin America

• Brazil

• Mexico

• Others

• Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.1 Key Industry Trends

5 Global Facial Injectables Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Collagen
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hyaluronic Acid (HA)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Botulinum Toxin Type A
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Calcium Hydroxylapatite (CaHA)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Poly-L-Lactic Acid (PLLA)
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast

7 Market Breakup by Application Type
7.1 Aesthetics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Therapeutics
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Application
8.1 Facial Line Correction
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lip Augmentation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Face Lift
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Acne Scar Treatment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by End-user
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Dermatology Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Allergan PLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Anika Therapeutics Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Bloomage BioTechnology
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Johnson & Johnson
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Galderma Pharma S.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Integra LifeSciences
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Ipsen (Mayroy SA)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Medytox Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Merz Holding GmbH & Co. KG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Prollenium Medical Technologies Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Sanofi
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 SciVision Biotech Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.14 Suneva Medical Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.15 Bausch Health Companies Inc
15.3.15.1 Company Overview
15.3.15.2 Product Portfolio
15.3.15.3 Financials
15.3.15.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/28ob35

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900